Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT05505071

DANTE SPACE for Evaluation of Subjects With Intracranial Vascular Disease

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of North Carolina, Chapel Hill · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Purpose: The purpose of this study is to evaluate the Delay Alternating with Nutation for Tailored Excitation (DANTE) SPACE sequence in clinical studies to determine whether it can provide more useful information for clinical diagnosis. Participants: 100 participants with concern for intracranial vascular disease scheduled to undergo a clinical vessel wall MRI will be recruited. Procedures (methods): Patients with concern for intracranial vascular disease scheduled to undergo a clinical vessel wall MRI who will have an additional non-FDA approved sequence (DANTE SPACE) added to their clinical scan. The investigational sequence requires less than 15 minutes and will be added following the standard MRI sequence.

Conditions

Interventions

TypeNameDescription
DEVICEDANTE SPACE sequenceinvestigational MRI sequence less than 15 minutes

Timeline

Start date
2022-12-01
Primary completion
2023-12-01
Completion
2023-12-01
First posted
2022-08-17
Last updated
2023-01-05

Regulatory

Source: ClinicalTrials.gov record NCT05505071. Inclusion in this directory is not an endorsement.